March 2017
Ibis President Kelly Blanchard joined a group of experts from several disciplines to release a commentary published last week in the New England Journal of Medicine highlighting the harms caused by overregulation of mifepristone in the United States. The FDA regulation mechanism known as REMS (Risk...